Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...
21h
Hosted on MSNLeerink Partners Downgrades 10x Genomics (TXG)Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...
Hosted on MSN1d
Why 10x Genomics (TXG) Shares Are Falling TodayWhat Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 8.5% in the pre-market session after the company ...
PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had a ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
China is building the world’s largest military command center that is at least 10 times bigger than the U.S. Pentagon. The Financial Times released a report about the base, citing information from U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results